A prospective study of a urine and plasma biomarker test for the prediction of gleason ≥3 + 4 prostate cancer in a mixed cohort

MLA

Martin Lund, et al. “A Prospective Study of a Urine and Plasma Biomarker Test for the Prediction of Gleason ≥3 + 4 Prostate Cancer in a Mixed Cohort.” Scandinavian Journal of Urology, vol. 54, July 2020, pp. 323–27. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0b91c4ab10297aba695a54d8c3182c98&authtype=sso&custid=ns315887.

APA

Martin Lund, Lars Lund, Mike Allan Mortensen, Charlotte Aaberg Poulsen, Søren Feddersen, Mads Hvid Poulsen, Maher Albitar, & Torben Pedersen. (2020). A prospective study of a urine and plasma biomarker test for the prediction of gleason ≥3 + 4 prostate cancer in a mixed cohort. Scandinavian Journal of Urology, 54, 323–327.

Chicago

Martin Lund, Lars Lund, Mike Allan Mortensen, Charlotte Aaberg Poulsen, Søren Feddersen, Mads Hvid Poulsen, Maher Albitar, and Torben Pedersen. 2020. “A Prospective Study of a Urine and Plasma Biomarker Test for the Prediction of Gleason ≥3 + 4 Prostate Cancer in a Mixed Cohort.” Scandinavian Journal of Urology 54 (July): 323–27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0b91c4ab10297aba695a54d8c3182c98&authtype=sso&custid=ns315887.